Tizanidine treatment of spasticity: A meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam

Advances in Therapy

Volumn 15, Issue 4, 1998, Pages 241-251

  Groves, Lesley ^a  

^a Athena Neurosciences Inc   (United States)

Author keywords

Baclofen; Diazepam; Meta analysis; Spasticity; Tizanidine; Tolerability

Indexed keywords

BACLOFEN; DIAZEPAM; TIZANIDINE;

ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; MUSCLE TONE; SPASTICITY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BACLOFEN; CEREBROVASCULAR DISORDERS; CLONIDINE; DIAZEPAM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; RANDOMIZED CONTROLLED TRIALS;

EID: 0031694407     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Davies J. Selective depression of synaptic transmission of spinal neurones in the cat by a new centrally acting muscle relaxant, 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiodazole (DS103-282). Br J Pharmacol. 1982;76:473-481.
2. Collingridge GL, Davies J. Reversible effects of tetanus toxin on striatal-evoked responses and [3H]-gamma-aminobutyric acid release in the rat substantia nigra. Br J Pharmacol. 1982;76:403-411.
3. Coward DM. Tizanidine: neuropharmacology and mechanism of action. Neurology. 1994;44:S6-S10.